Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| MK-0000-419 | Other Identifier | MSD |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In this study, researchers want to learn if a watch can be used to track physical activity in healthy people. The watch will collect the data and send it to a database using a data storage device.
The goal of this study is to measure:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Watch Wearing to Track Activity | Experimental | Participants wear a watch that tracks physical activity throughout study. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Activity Tracking Watch | Device | Device includes a wristwatch that tracks physical activity and a data storage unit that transmits data to a central database. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants that Wear Watch as Instructed | The number of participants that wear the watch for at least 19.2 hours per day (80% of the time) will be reported. | Up to approximately 2 weeks |
| Number of Provisioned Watches and Data Storage Devices That Were Returned | The number of watches and data storage devices provisioned and returned free from malfunction will be reported. | Up to approximately 2 weeks |
| Number of Watches and Data Storage Devices that Successfully Transmit Data | The number of watches and data storage devices that successfully transmit data to central database will be reported. | Up to approximately 2 weeks |
| Average Daily Overall Activity Count | The average daily overall activity will be reported. | Up to approximately 2 weeks |
| Average Daily Total Step Count | The number of average daily total steps will be reported. | Up to approximately 2 weeks |
| Average Daily Time (minutes) in Nonsedentary Activity | The average daily time spent in nonsedentary activity will be reported. | Up to approximately 2 weeks |
| Average Daily Time (minutes) in Moderate-to-Vigorous Physical Activity | The average daily time spent in moderate-to-vigorous physical activity will be reported. |
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants Who Experience an Adverse Event (AE) | An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. The number of participants who experience an AE will be reported. | Up to approximately 2 weeks |
Not provided
Inclusion Criteria:
The key inclusion criteria include but are not limited to:
Exclusion Criteria:
The key exclusion criteria include but are not limited to:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Medical Director | Merck Sharp & Dohme LLC | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| QPS-MRA, LLC (Site 0001) | South Miami | Florida | 33143 | United States | ||
| Altasciences Clinical Kansas, Inc. (Site 0002) |
Not provided
| Label | URL |
|---|---|
| Merck Clinical Trials Information | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Up to approximately 2 weeks |
| Number of Participants Who Discontinue Study Intervention Due to an AE | An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. The number of participants who discontinue study intervention due to an AE will be reported. | Up to approximately 2 weeks |
| Overland Park |
| Kansas |
| 66212 |
| United States |